CELL TECHNA GENE THERAPY
LIVE

Serial Number

79301167

Owner

UAB "Northway turto valdymas"

Attorney

John Zaccaria

Filing Date

Oct 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELL TECHNA GENE THERAPY Trademark

Serial Number: 79301167 • Registration: 6610212

CELL TECHNA GENE THERAPY is a trademark filed by UAB "Northway turto valdymas" on October 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

UAB "Northway turto valdymas" (17 trademarks)

S.Zukausko g. 21-43

Entity Type: 99

Trademark Details

Filing Date

October 14, 2020

Registration Date

January 11, 2022

Published for Opposition

October 26, 2021

Goods & Services

Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19

Medical services; midwife services; alternative medicine services; in vitro fertilization services; chiropractic services; physiotherapy; occupational therapy services; human tissue bank services; hospital services; rental of medical equipment; medical advice for individuals with disabilities; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; opticians' services; plastic surgery; services of a psychologist; convalescent home services; preparation of prescriptions by pharmacists; rehabilitation of substance abuse patients; nursing, medical; health centre services; health counselling; medical screening; health care; telemedicine services

Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; scientific laboratory services; technological consultation in the field of development of manufacturing processes for biotechnology products

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 11, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 14, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 14, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 14, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 14, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 14, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 14, 2021 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2021 NREP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 18, 2021 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
May 16, 2021 CRCV
REFUSAL PROCESSED BY IB
Apr 13, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 22, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 22, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 6, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR